Delivery Order SPE2DB22D2007-SPE2DB25FJ4YV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT 25 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive delivery order executed by the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of AYVAKIT 25 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $73,106.76, is scheduled for completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency Medical Supply Chain awarded a $48,737.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ayvakit 25 mg tablets in a 30-count package. This firm fixed-price delivery order, valued at $48,737.84, represents a non-set-aside competitive award and is scheduled for completion by September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This competitive award, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $21,918 to Amerisourcebergen Drug Corporation to supply 4561812928 AYVAKIT 300 MG tablets. Under the terms of the order, Amerisourcebergen will deliver 30 boxes of the medication to a location in Conshohocken, Pennsylvania, with performance required between August 10 and 31, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will fulfill this order to support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AYVAKIT 25 MG TABLET 30S. The contract has a potential value of $23,325.68 and a completion date of March 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to provide pharmaceutical products and medical supplies in support of military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a 30-count quantity, with a ceiling value of $24,368.92 and a firm fixed-price structure. This delivery order is not set-aside and represents a competitive award under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion master contract vehicle valued through December 2026 that enables...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $23,325.68 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AYVAKIT 25 MG TABLET 30S. This contract has an ultimate completion date of August 12, 2024 and is not set aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a wide range of...
- This delivery order, awarded on August 25, 2025, authorizes AmerisourceBergen Drug Corp to supply 30 tablets of Ayvakit 25 mg under a firm fixed-price arrangement with a ceiling value of $24,368.92. The contract is performed at the company's corporate office in Conshohocken, Pennsylvania, and must be completed by September 16, 2025. The Defense Logistics Agency, under the Department of Defense, issued this non-competitive delivery order as a child contract utilizing AmerisourceBergen's...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4YVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT 25 mg tablets (30-count units) on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this requirement as part of its extensive portfolio of federal medical product deliveries. The company serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order contributes to the Defense Health Agency's pharmaceutical supply chain and reflects AmerisourceBergen's established capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 9/15/25 |